Efficacy and factors influencing treatment with peginterferon alpha-2a and ribavirin in elderly pati

来源 :国际肝胆胰疾病杂志:英文版 | 被引量 : 0次 | 上传用户:duancj1972
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND:In China,hepatitis C virus(HCV) infection is characterized by an increasing prevalence during aging.This study was undertaken to evaluate the efficacy of treatment with peginterferon alpha-2a and ribavirin in elderly chronic hepatitis C(CHC) pa
其他文献
BACKGROUND:In vitro experiments and mice models have confirmed the importance of Sprouty 2(Spry2) in inhibiting tumorigenesis and the progression of human cance
BACKGROUND: The relationship between cytokines and responses to peginterferon α-2a treatment in chronic hepatitis B patients has not yet been fully elucidated.
BACKGROUND: The microenvironment within solid tumors has often been shown to exhibit an acidic extracellular pH. Although the morphologic and functional differe
【正】Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided
期刊
BACKGROUND:After pancreaticoduodenectomy,the incidence of postoperative pancreatic fistula remains high,especially in patients with "soft" pancreatic tissue rem
BACKGROUND:Portal hyperperfusion in the small-for-size (SFS) liver can threaten survival of rabbits.Therefore,it is important to understand the hemodynamic chan
BACKGROUND:The traditional hand-sewn Roux-en-Y choledochojejunostomy is technically complicated,and the incidence of postoperative complications has remained hi
BACKGROUND: Glycogen synthase kinase (GSK)-3β/β-catenin signaling regulates ischemia-reperfusion (I/R)-induced apoptosis and proliferation, and inhibition of
BACKGROUND: Castleman disease is an uncommon lympho-proliferative disorder most frequently occurring in the mediastinum. Abdominal forms are less frequent, with
BACKGROUND:Pancreatic cancer is a highly aggressive malignant tumor with the lowest survival rate.A better understanding of the molecular mechanisms which contr